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Isolation and characterization of βA3-crystallin associated
proteinase from α-crystallin fraction of human lenses
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Purpose: The purpose was to characterize the properties of a proteinase activity associated with βA3-crystallin, which
was isolated from the α-crystallin fraction of human lenses.
Methods: An inactive, Arg-bond hydrolyzing proteinase in the α-crystallin fraction, which was isolated from the water
soluble (WS) protein fraction of 60- to 70-year-old human lenses, was activated by sodium deoxycholate treatment. The
activated enzyme was purified by a three-step procedure that included a size-exclusion Agarose A1.5 m chromatography,
non-denaturing preparative gel-electrophoresis, and size-exclusion HPLC. The purified proteinase was characterized for
the proteinase type, proteolysis of bovine recombinant γB-, γC-, and γD-crystallins, and its presence in three different
protein fractions of human lenses (i.e., α-crystallin, βH-crystallin, and membrane fractions).
Results: An inactive, Arg-bond hydrolyzing proteinase present in the α-crystallin fraction showed activity on treatment
with detergents such as sodium deoxycholate, Triton X-100, octyl β-D-glucopyranoside, and CHAPS (3-[(3-cholamido
propyl) dimethylammonio]-1-propanesulfonate). The sodium deoxycholate-activated enzyme was released from the α-
crystallin fraction since it eluted at a lower molecular weight species than α-crystallin during size-exclusion Agarose A1.5
m chromatography. Following a three-step purification procedure, the enzyme showed three species between 22 kDa and
25 kDa during sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS–PAGE) analysis. The three protein bands
were  identified  as  βA3-,  βB1-,  and  βB2-crystallin  by  the  matrix-assisted  laser  desorption/ionization-time  of  flight
(MALDI-TOF) and tandem mass spectrometric (ES-MS/MS) methods. Inhibitor studies revealed that the enzyme was a
serine-type proteinase. Among the recombinant βA3-, βB1-, or βB2-crystallins, only the βA3-crystallin exhibited the
proteinase activity following detergent treatment and size-exclusion chromatography. The proteinase also exhibited
proteolysis of γC- and γD- crystallins, and the cleavage of γD-crystallin at M1-G2, Q54-Y55, M70-G71, and Q103-M104 bonds.
Further, the enzyme was also present in three fractions of human lenses (α-crystallin, βH-crystallin, and membrane
fractions).
Conclusions: A serine-type βA3-crystallin proteinase existed in an inactive state in the α-crystallin fraction and was
activated by detergents. The enzyme proteolyzed αA-, αB-, γC-, and γD-crystallins and was present in three fractions
(α-crystallin, βH-crystallin, and membrane-fractions) of 60 to 70-year-old human lenses.
The vertebrate lens contains several endopeptidases such
as a neutral proteinase (a multicatalytic proteasome) [1,2], a
25 kDa proteinase [3], calpain I and calpain II [4], an Lp82
calpain [5], a membrane-associated proteinase [6,7], a Ca+2-
dependent protease [8], and caspase-3 and caspase-6 [9-11].
Additionally, the existence of ubiquitin-proteasome activity
has been described in the lens [12]. In spite of the existence
of  so  many  proteinases,  the  lens  exhibits  a  low  protein
turnover rate [13], which is further suggested by the limited
degradation of α-, β-, and γ-crystallins in mammalian lenses.
However, truncation of the crystallins increases with aging
and cataractogenesis in human lenses for reasons yet unknown
[14-19].
Our previous studies have shown that the human lens 25
kDa  proteinase  [3]  and  a  membrane  proteinase  [6,7]
hydrolyzed  the  Arg-bond-containing  substrates.  More
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recently,  we  presented  evidence  that  the  Arg-bond
hydrolyzing proteinase activity was associated with βA3/A1-
crystallin [20]. The properties of the enzyme were apparently
similar to a previously studied 25 kDa proteinase [3] and a
membrane proteinase [6,7], both of which needed activation
and were a serine-type. The results suggested that the βA3/
A1-crystallin proteinase might be present in water soluble
fractions and associated with the membranes in human lenses.
Our previous results [3,6,7,20] have also shown that the
Arg-bond hydrolyzing lens proteinase existed in an inactive
state  and  was  activated  by  either  metal  ions  [3]  or  by  a
detergent such as sodium deoxycholate [20]. Although the
proteinase  existed  in  an  inactive  state  possibly  due  to  its
inhibition by α-crystallin as suggested in previous studies
[21-27] and in the reports that show inhibition of trypsin
[24] and elastase [26] by α-crystallin, the presence of the
enzyme in an inactive state in the α-crystallin fraction has not
been investigated.
With the exception of our report of βA3-crystallin as the
proteinase [20] and the observation that recombinant βA3-
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1872crystallin readily degrade to 20–25 kDa major species during
purification and on storage, no other report has suggested such
an association between enzyme activity and the crystallin.
Nevertheless, suggestive evidence exists in one report [28],
which showed that βA3/A1-crystallin, upon ultraviolet (UV)
irradiation, exhibited degradation and multimer formation in
species higher than 27 kDa. Although the report attributed the
disappearance  of  the  crystallin  to  increasing  doses  of
irradiation, the observed pattern was similar to what we have
observed during sodium deoxycholate-induced activation of
proteinase activity in βA3-crystallin. Presently, the molecular
events that lead to the activation of proteinase activity in the
crystallin is not fully understood, except that the truncation in
the NH2-terminal extension and altered conformation of the
crystallin  are  required.  The  age-related  NH2-terminal
truncation  in  βA3/A1-crystallin  has  been  demonstrated  in
fetal and adult bovine lenses with the absence of NH2-terminal
11  and  22  amino  acids  [29].  Similarly,  NH2-terminal
truncations of βB1- and βA3/A1-crystallins in three-year-old
human lenses was also reported [30], and we showed that age-
related progressive NH2-terminal truncations in human βA3-
crystallin produce 4-18 kDa species with a major cleavage at
the E39-N40 bond [15]. The potential effects of these in vivo
NH2-terminal  truncations  on  crystallin  structure  and
proteinase function have not been studied.
Based on our previous results as described above, we
hypothesized that because α-crystallin acts as an inhibitor of
βA3-crystallin proteinase, a proteinase/α-crystallin complex
might exist in the α-crystallin fraction of human lenses. To
test  this  hypothesis,  we  used  the  α-crystallin  fraction  to
activate and purify the proteinase and examined whether the
enzyme  activity  was  associated  with  βA3-crystallin.  In
addition, we have also examined whether this enzyme exists
in the α-crystallin, βH-crystallin, and membrane fractions of
human lenses.
METHODS
Materials: Normal human lenses with no apparent opacity
were obtained from Dr. Robert Church (Emory University,
Atlanta, GA). The retrieved lenses were stored at −20 °C in
Medium 199 (without phenol red) until used. The prestained
and  unstained  molecular  weight  markers  were  from  GE
Biosciences (Piscataway, NJ). Unless indicated otherwise, all
the other chemicals used in this study were purchased from
either Sigma (St. Louis, MO) or Fisher (Atlanta, GA). The
recombinant βA3/A1-crystallin was expressed in Escherichia
coli and purified in our laboratory as previously reported
[31]. The recombinant βB1- and βB2-crystallins were a gift
from Dr. Kirsten Lampi (Oregon Health Sciences University,
Portland, OR).
Isolation  of  human  lens  α-crystallin  fraction:  The  water
soluble (WS) protein fraction from 20 pooled lenses of 60 to
70-year-old  donors  was  prepared  as  previously  described
[17,32]. Briefly, each lens was thawed on ice, decapsulated,
suspended (2 ml/lens) in buffer A (50 mM Tris-HCl, pH 7.9,
containing 1 mM dithiothreitol [DTT], 1 mM iodoacetamide,
1  mM  phenylmethylsulfonyl  fluoride),  and  homogenized
using a tissue grinder. The lens homogenate was centrifuged
at 25,000x g for 15 min. The supernatant was recovered and
the  pellet  was  homogenized  and  centrifuged  twice  as
described  above.  The  supernatants  recovered  after  each
centrifugation were pooled and designated as the WS protein
fraction, and the pellet was designated as the water insoluble
(WI) protein fraction. The WS protein fraction was subjected
to size-exclusion chromatography using an Agarose A5 m
column (2.5×40 cm) to recover the high molecular weight
(HMW) protein fraction as well as α-, βH-, βL-, and γ-crystallin
fractions. The individual column fractions were analyzed by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS–PAGE) to identify the presence of specific crystallins,
and each of the fractions were individually pooled, dialyzed
against a desired buffer, and stored at −20 °C before use.
Proteinase activity in α-crystallin fraction: The Arg-bond
hydrolyzing  proteinase  activity  was  measured  by  the
hydrolysis  of  either  N-benzoyl  DL-Arg  p-nitroanilide
(BAPNA) or CBZ-L-Arg 7-amino 4-methyl coumarin as a
substrate (see below the method for enzyme assay) in the α-
crystallin  and  in  other  desired  protein  preparations.  The
proteinase activity in the α-crystallin fraction was determined
by the following three methods: (1) The α-crystallin fraction
was treated with 2% sodium deoxycholate (w/v), and the
activity was determined in the detergent-treated and untreated
fractions  following  size-exclusion  Agarose  A  1.5  m
chromatography;  (2)  the  α-crystallin  was  treated  with
individual detergents (sodium deoxycholate, sodium dodecyl
sulfate [anionic], Triton X-100, octyl β-D-glucopyranoside
[non-ionic],  or  3-[(3-Cholamidopropyl)
dimethylammonio]-1-propanesulfonate  [CHAPS;  a
zwitterion]), and the proteinase activity was determined; or
(3)  the  sodium  deoxycholate-treated  and  untreated  α-
crystallin fractions were incubated at 37 °C for 10 h and then
subjected to two-dimensional gel electrophoresis as described
previously [15]. The polypeptide spots that were present only
in  the  detergent-treated  α-crystallin  preparation  were
identified, excised, and analyzed by the matrix-assisted laser
desorption/ionization-time  of  flight  (MALDI-TOF)  mass
spectrometric method.
Purification of the Arg-bond hydrolyzing proteinase from the
α-crystallin fraction: An Arg-bond hydrolyzing proteinase
was purified by a three-step procedure from the α-crystallin
fraction of normal lenses of 60- to 70-year-old donors. All the
purification steps were performed at 5 °C unless indicated
otherwise.  In  the  first  step,  the  α-crystallin  fraction  was
prepared as described above from the WS protein fraction by
a size-exclusion Agarose A 1.5 m chromatography, treated
with sodium deoxycholate (final concentration of 2% [w/v]),
and chromatographed through an Agarose A1.5 m column
(5×80 cm). The column equilibration and sample elution were
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the second step, the proteinase-containing fractions from the
Agarose column were pooled, concentrated by lyophilization,
and dialyzed against 10X excess of buffer A. The preparation
was then subjected to preparative non-denaturing gel (10%
polyacrylamide gel) electrophoresis using a Bio-Rad Prep
Cell (model 491; Hercules, CA). The fractions were recovered
as proteins that were eluted from the preparative gel and
analyzed for enzyme activity with BAPNA as a substrate and
for  protein  species  by  SDS–PAGE  [33].  The  enzyme-
containing  fractions  were  pooled,  concentrated  by
lyophilization, and dialyzed against 0.05 M phosphate buffer,
pH 7.5. In the third step, the proteinase-containing fractions
were  fractionated  by  HPLC  using  a  size-exclusion  TSK
G3000  PWXL  column  (TosoHaas,  Montgomeryville,  PA).
During HPLC, the column equilibration and sample elution
were performed with 0.05 M phosphate buffer, pH 7.5. The
proteinase-containing fractions were pooled, dialyzed against
a 2,000 volume excess of phosphate buffer at 5 °C for 48 h,
and stored at −20 °C.
Identification of protein species in the purified proteinase
preparation:  The  purified  proteinase  preparation  was
examined by SDS–PAGE and the identity of the protein bands
were  established  by  MALDI-TOF  and  the  tandem  mass
spectrometric  (ES-MS/MS)  methods.  MALDI-TOF  MS
analysis and ES-MS/MS sequencing (Micromass Q-TOF 2;
Waters-Micromass, Manchester, UK) were performed at the
Comprehensive  Cancer  Center  Mass  Spectrometry  Shared
Facility of the University of Alabama at Birmingham. For
mass  spectrometric  analysis,  the  individual  protein  spots/
bands were excised from a SDS–PAGE gel using pipette
microtips. The polyacrylamide pieces containing individual
bands were destained with three consecutive washes with a
50:50  mixture  of  25  mM  ammonium  bicarbonate  and
acetonitrile for 30 min. Next, the samples were washed for 10
min with 25 mM ammonium bicarbonate before digestion
with trypsin (12 ng/μl; sequencing grade from from Roche,
Applied Sciences, Indianapolis, IN) for 16 h at 37 °C. Peptide
solutions were then extracted using 100 μl of a 50:50 mixture
of 5% formic acid and acetonitrile for 30 min. Supernatants
were  collected  and  evaporated  to  dryness  in  a  Savant
SpeedVac  (Marietta,  OH).  Samples  were  resuspended  in
10 μl of 0.1% formic acid. C-18 ZipTips (Millipore, Billerica,
MA) were used to desalt peptide mixtures before applying
samples to the MALDI-TOF 96 well spot, gold-coated target
plates. Bound peptides were eluted from the ZipTips with
10 μl of 80% acetonitrile containing 0.1% formic acid. They
were mixed (1/10 dilution) with a saturated solution of α-
cyano-4-hydroxycinnamic  acid  (CHCA)  matrix  in  50%
aqueous acetonitrile. Samples were allowed to dry before
performing MALDI-TOF MS using a Voyager DE-Pro (ABI,
Foster City, CA) with a nitrogen laser (337 nm) operating in
positive mode. Spectra were the sum of 100 laser shots – they
were then de-isotoped and analyzed using Voyager Explorer
Software (Applied Biosystems, Forest City, CA), and peptide
masses were submitted to the MASCOT search engine for
protein identification. The potential identity of the proteins
was  determined  by  using  the  NCBInr  database  (National
Center  for  Biotechnology  Information,  Bethesda,  MD).
Tandem mass spectral analyses were performed with the Q-
TOF 2 mass spectrometer using electrospray ionization to
verify the identity of the proteins. The tryptic peptides used
for the MALDI-TOF MS analysis were then analyzed by LC-
MS/MS. Liquid chromatography was performed using a LC
Packings Ultimate LC-Switchos microcolumn switching unit
and Famos autosampler (LC Packings, San Francisco, CA).
The samples were concentrated on a 300 μm i.d. C8 reverse-
phase precolumn at a flow rate of 10 μl/min with 0.1% formic
acid and then flushed onto a 10 cm×75 μm i.d. C8 reverse-
phase column at 200 μl/min with a gradient of 5%–100%
acetonitrile  in  0.1%  formic  acid  for  30  min.  The
nanoelectrospray ionization interface was used to transfer the
LC  eluent  into  the  mass  spectrometer.  The  Q-TOF  was
operated in the automatic switching mode where multiple-
charged ions were subjected to MS/MS if their intensities rose
above six counts. Protein identification was performed by
either ProteinLynx Global Server software (Waters, Milford,
MA) or by manual interpretation.
Additional studies:
Nature of the α-crystallin-associated proteinase—A
variety of inhibitors were used to determine the nature of the
proteinase.  These  included  phenylmethylsulfonyl  fluoride
(PMSF; 1 mM), diisopropyl fluorophosphate (DFP; 1 mM),
and benzamidine (10 mM) as serine proteinase inhibitors;
ethylenediamine  tetraacetic  acid  (EDTA;  10  mM)  and
diethyldithiocarbamic  acid  (10  mM)  as  metalloproteinase
inhibitors; and iodoacetamide (3 mM) and iodoacetic acid
(3 mM) as cysteine proteinase inhibitors. Percent inhibition
of  the  enzyme  by  an  inhibitor  was  determined  following
incubation with BAPNA at 37 °C for 30 min.
Structural  changes  in  βA3-crystallin  following
proteinase activation on sodium deoxycholate treatment
—The purified recombinant His-tagged wild type (WT) βA3
(Mr ~32 kDa) was treated with 0.1% sodium deoxycholate and
fractionated by size-exclusion HPLC using a TSK G3000
PWXL column. The column fractions containing proteinase
activity  were  analyzed  by  SDS–PAGE.  The  fractions
representing  the  highest  proteinase  activity  peak  and  a
detergent-untreated βA3-crystallin preparation were analyzed
by SDS–PAGE. The partial NH2-terminal sequence of the
major bands in the two fractions was determined at the Iowa
State  University  Protein  Core  Facility  (Ames,  IA).  The
detergent-untreated  and  detergent-treated  βA3-crystallin
preparations  with  proteinase  activity  were  used  for  the
determination of structural changes as previously described
[31]. The analyses included surface hydrophobicity changes
by  ANS  (8-anilino-1-naphthalenesulfate,  a  hydrophobic
probe)-binding, Trp microenvironmental changes by intrinsic
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changes by circular dichroism (CD) spectral determination.
The fluorescence spectra were recorded in corrected spectrum
mode  using  a  spectrofluorometer  (Shimadzu  Scientific
Instruments, Columbia, MD) with excitation and emission
band passes set at 5 nm and 3 nm, respectively. The binding
of a hydrophobic probe, ANS, to βA3-crystallin preparations
was  determined  by  recording  fluorescence  spectra  after
excitation at 390 nm and emission between 400 and 600 nm.
In these experiments, 15 μl of 0.8 mM ANS (dissolved in
methanol) was added to a protein preparation (0.1 mg/ml,
dissolved in 10 mM phosphate buffer, pH 7.4). The samples
were incubated at 37 °C for 15 min before the fluorescence
measurements. The intrinsic Trp fluorescence intensities of
the  βA3-crystallin  preparations  (0.1  mg/ml  of  each)  were
recorded with an excitation at 295 nm and emission between
300 and 400 nm. The secondary structural changes in the
βA3-crystallin  preparations  were  determined  by  recording
their far-UV CD spectra at room temperature using an AVIV
Spectropolarimeter  (Model62DS;  AVIV,  Lakewood,  NJ).
The βA3-crystallin preparations of 0.1–0.2 mg/ml (dissolved
in 50 mM Tris-HCl, pH 7.9) were used for recording the far-
UV CD spectra. The path length was 0.1 cm during the far-
UV CD spectra determination. The spectra reported are the
average  of  five  scans,  corrected  for  buffer  blank  and
smoothed.  Secondary  structures  were  estimated  using  the
SELCON program [34].
Determination  of  the  Arg-bond  hydrolyzing
proteinase activity in water soluble protein, α-crystallin,
βH-crystallin, and membrane fractions—The WS protein
fraction was isolated from six pooled lenses from 30 to 40-
year-old donors and the α-, βH-, βL-, and γ-crystallin fractions
were isolated by Agarose A1.5 m column chromatographic
method as described above. Individual α-, β H-, βL-, and γ-
crystallin  species  were  collected  following  SDS–PAGE
analysis of the column fractions. The WI protein fractions
from these lenses were used to isolate the membrane fraction
by a urea wash method as previously described [6].
To activate proteinase activity, the individual WS protein,
α-,  and  βH-crystallin  fractions  were  treated  with  sodium
deoxycholate (2% w/v, final concentration) and fractionated
by an Agarose A1.5 m column. The column fractions were
analyzed for the Arg-bond hydrolyzing proteinase activity
using BAPNA as a substrate. The membrane fraction was also
extracted  with  2%  (w/v;  final  concentration)  sodium
deoxycholate for 20 h at 4 °C, centrifuged at 15,000x g for 15
min, and the supernatant was chromatographed as above to
determine  the  enzyme  activity.  The  enzyme  preparations
isolated from each of the four fractions (i.e., WS protein, α-
crystallin, βH-crystallin, and membrane fractions) were further
subjected  to  nondenaturing  polyacrylamide  (10%)  gel
electrophoresis using Bio-Rad Prep Cell (model 491), and the
enzyme-containing fractions were collected, concentrated by
lyophilization, dialyzed at 4 °C against 0.05 M phosphate
buffer, pH 7.5, and stored frozen at −20 °C until use.
To determine whether a single proteinase exist in the
above  four  fractions  of  human  lenses,  the  following
experiments were performed: (1) The elution of proteinase
following Agarose A1.5 m chromatography of the above four
fractions were compared to determine whether the enzyme
had  identical  Mr  and,  therefore,  coeluted  in  the  identical
fractions during chromatography; (2) a further confirmation
of an identical Mr of the proteinase in the above four fraction
was  performed  by  a  size-exclusion  HPLC  using  a  TSK
G-4000 PWXL column. The individual proteinase preparations
that were recovered from the four fractions after Agarose A1.5
m  chromatography  were  analyzed  by  HPLC,  and  the
proteinase  activity  was  determined.  Again,  the  column
fractions were analyzed as above for the enzyme activity; (3)
to further determine the presence of a single proteinase, the
individual enzyme preparations that were recovered following
Agarose A1.5 m chromatography of the four fractions were
combined and subjected to a preparative nondenaturing gel-
electrophoresis with 10% polyacrylamide gel using a Bio-Rad
Prep Cell (Model 491). The eluent from the gel was collected
in different fractions and analyzed for the proteinase activity
as above with BAPNA as a substrate; and (4) the purified
proteinase preparations from the above four fractions were
analyzed  for  their  caseinolytic  activity  by  the  method  as
described  [35].  The  purpose  of  this  experiment  was  to
determine  whether  the  enzyme  recovered  from  the  four
fractions  shows  comigrating  caseinolytic  bands  on  a  gel
during nondenaturing gel electrophoresis.
Proteolysis  of  bovine  recombinant  γB-,  γC-,  and  γD-
crystallins by βA3-crystallin proteinase-
Bovine  recombinant  γB-,  γC-,  and  γD-crystallins
(obtained from Dr. Mark Petrash, Washington University, St.
Louis, MO) were incubated with the proteinase (isolated from
the membrane fraction) for 48 h at 37 °C at the ratio of 1:40
Figure 1. SDS–PAGE analysis of the column fractions that contained
proteinase activity after Agarose A1.5 m chromatography of the
sodium  deoxycholate-treated  α-crystallin  fraction.  Note  that  two
protein bands (identified as bands 1 and 2) with Mr of 20–25 kDa
and the third band (identified as band 3) of 38 kDa were recovered.
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24 and 48 h of incubation were analyzed by SDS–PAGE. The
proteolyzed species were transferred to a PVDF membrane
[36],  briefly  stained  with  Coomassie  blue,  and  individual
proteolyzed  species  were  analyzed  for  their  partial  NH2-
terminal sequences at the Core Facility of the University of
Alabama at Birmingham.
Miscellaneous methods: The proteinase activity was assayed
with two methods as previously described [3,6,7]. In the first
method, benzoyl DL-Arg p-nitroanilide (BAPNA) was used
as a substrate, and the assay was performed for 4 h or for 16-24
h at 37 °C. In the second fluorometric assay, a 3.0 ml reaction
mixture  contained  0.1  ml  of  0.1  mM  coumarin  substrate
solution (CBZ-L-Arg 7-amino 4-methyl coumarin, excitation
at  380  nm  and  emission  at  460  nm),  0.1  ml  of  enzyme
preparation and 2.8 ml of 0.05 M Tris-HCl, pH 7.8. The
reaction mixture was incubated at 37 °C for 5 min and enzyme
activity  determined  using  a  Turner  model  430
spectrofluorometer  (Sequoia-Turner  Corporation,
Mountainview,  CA),  water-jacketed  cuvette  holder  and
Houston chart recorder (Houston Instrument, Austin, TX).
With the coumarin substrate, one enzyme unit (e.u.) is defined
as  the  production  of  0.1  nanomole  of  7-amido-4-methyl
coumarin per min. The use of a specific substrate for the
enzyme assay in the experiments has been identified.
The pI (isoelectric point) of the purified proteinase was
determined using a Bio-Rad isoelectric focusing apparatus
(Rotofor Preparative IEF Cell). Protein determination was
performed using the Pierce protein determination kit (Pierce
Chemical  Co.,  Rockford,  IL)  using  the  manufacturer’s
supplied method.
RESULTS
An Arg-bond hydrolyzing proteinase exists in the α-crystallin
fraction:  The  following  three  experiments  suggested  the
presence of an Arg-bond hydrolyzing proteinase in the α-
crystallin fraction of human lenses. In the first experiment, no
proteinase activity was observed in the α-crystallin fraction of
human lenses of 60 to 70-year-old donors until the preparation
was treated with sodium deoxycholate and fractionated by a
size-exclusion  Agarose  A1.5  m  column.  Following
chromatography, the proteinase eluted later than α-crystallin,
Figure 2. Proteolysis of αA- and αB-crystallins following incubation of the α-crystallin fraction with sodium deoxycholate at 37 °C for 10 h.
Deoxycholate untreated α-crystallin fraction (A) and deoxycholate (2% w/v)-treated α-crystallin fraction (B; each containing 190 μg protein
at 37 °C for 10 h) were analyzed by two-dimensional gel electrophoresis, and those spots present in only the deoxycholate-treated preparations
were identified and numbered as 1-9 as shown in (B). Each spot was analyzed by the MALDI-TOF mass spectrometric method to determine
their identity.
TABLE 1. DISSOCIATION OF PROTEINASE ACTIVITY FROM α-CRYSTALLIN FRACTION.
Detergents concentration Type Proteinase activity (e.u./ml)*
Sodium deoxycholate (1%) Anionic 1.04
Sodium dodecyl sulfate (0.1%) Anionic 1.05
Triton X-100 (0.1%) Non-ionic 0.5
Octyl-β-D-glucopyranoside (0.2%) Non-ionic 0.8
CHAPS (0.2%) Zwitterion 1.05
The proteinase activity was determined following detergent treatment of α-crystallin fraction. The asterisk indicates that
proteinase activity is expressed as e.u./ml with BAPNA as a substrate. One e.u. is defined as the release of 1 nm/h of p-nitroanilide
from BAPNA. Proteinase activity was determined by detergent treatment of the α-crystallin fraction followed by size-exclusion
HPLC using a TSK G-3000 PW XL column.
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than  the  crystallin.  On  examination  of  the  fractions  that
contained proteinase activity by SDS–PAGE, three protein
bands, two of about 22–25 kDa and one of about 38 kDa, were
observed (Figure 1). Similar results were obtained with the
α-crystallin  fraction  isolated  from  lenses  of  20-year-old
donors, suggesting that the association of the enzyme with the
crystallin occurred early during aging (results not shown). In
the  second  experiment,  the  dissociation  of  the  proteinase
activity  from  the  α-crystallin  fraction  following  treatment
with  sodium  deoxycholate  (anionic,  0.1%  final
concentration), Triton X-100 (non-ionic, 0.1%), octyl β-D-
glucopyranoside  (non-ionic,  0.2%),  and  CHAPS
(zwitterionic, 0.1%) was also observed. All other detergents
except Triton X-100 were able to dissociate the enzyme at
almost the same levels (1.0 enzyme units from 0.8 mg protein
per ml from the α-crystallin fraction; Table 1). The third
experiment showed that the activation of the enzyme also
resulted in the proteolysis of α-crystallin. With the sodium
deoxycholate treatment of α-crystallin and incubation under
sterile  conditions  at  37  °C  for  10  h,  the  α-crystallin
preparations showed proteolysis, which was absent in the
detergent-untreated  preparation  (Figure  2A,B).  Upon
MALDI-TOF mass spectrometric analysis, the proteolyzed
fragments of both αA- and αB-crystallins were identified (i.e.,
spot no. 6 [Mr 10 kDa] was of αB-crystallin and spot no. 1-5
and 7-9 [Mr 6–14 kDa] were of αA-crystallin).
Purification of an Arg-bond hydrolyzing proteinase from α-
crystallin fraction: The α-crystallin fraction, isolated from 60
to 70-year old human lenses, was used for the dissociation and
purification of the enzyme by a three-step procedure (see
Methods).  Following  sodium  deoxycholate  treatment  and
size-exclusion Agarose A1.5 m chromatography, the enzyme
was released, and the proteinase-containing fractions showed
a band of about 38 kDa and two bands of 22–25 kDa (Figure
1). The 38 kDa band was identified as keratin by MALDI-TOF
mass spectrometric analysis. Upon further purification of the
proteinase  by  the  second  step  of  nondenaturing  gel-
electrophoresis followed by the third step of size-exclusion
HPLC, the 22–25 kDa species were progressively purified
(Figure 3). Further, no additional species greater than 90 kDa
were present in the purified fraction as determined by using
7% polyacrylamide gel during SDS–PAGE analysis (results
not shown).
The specific activity and fold purification at various steps
of enzyme purification are shown in Table 2. The specific
activity of the proteinase after the three-step purification was
500 with a 1,094 fold increase in specific activity.
Identification of the protein species in the purified proteinase
preparation: SDS–PAGE analysis of the purified proteinase
preparation showed three protein bands of 22-25 kDa (Figure
4).  The  five  such  purified  preparations  showed  identical
protein bands. The ES-MS/MS analysis identified band 1 as
βA3-crystallin  (contained  residue  #33–45
[ITIYDQENFQGKR], #35–45 [IYDQENFQGKR], #36–45
[YDQENFQGKR],  #126–137  [MTIFEKENFIGR],  #128–
137  [IFEKENFIGR],  and  #197–211
[EWGSHAQTSQIQSIR]). Band 2 was identified as a mixture
of  βA3-,  βB1-,  and  βB2-crystallins  as  it  showed  peptide
sequences of βA3 (residue # 33–44 [ITIYDQENFQGK] and
#96-109  [WDAWSGSNAYHIER]),  βB1  (residue  #60–71
[LVVFELENFQGR],  residue  #123–131  [WNTWSSSYR],
#150–159  [ISLFEGANFK],  #187–201
[VSSGTWVGYQYPGYR],  and  #202–214
[GYQYLLEPGDFR]),  and  βB2  (residue  #110–120
Figure 3. SDS–PAGE analysis of various fractions recovered during
purification of α-crystallin-associated fractions. Lane 1: α-Crystallin
fraction was recovered from a WS protein fraction of lenses that were
60-  to  70-years-old.  Lane  2:  Concentrated  α-crystallin  fraction
applied to the Agarose A1.5 m column. Lane 3: Proteinase fractions
recovered  following  non-denaturing  gel  electrophoresis  of  the
proteinase  fraction  released  after  Agarose  A1.5  m  gel
chromatography. Lane 4: A proteinase-containing fraction recovered
following size-exclusion HPLC using TSK G-4000 PWXL column of
the fraction recovered in lane 3.
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1877[LYENPNFTGKK],  #129–139  [PSFHAHGYQEK],  and
#145–159  [VQSGTWVGYQYPGYR]).  Band  3  was
identified  as  βB1-crystallin  (contained  residue  #60–71
[LVVFELENFQGR], #150–159 [ISLFEGANFK], #187–201
[VSSGTWVGYQYPGYR],  #202–214
[GYQYLLEPGDFR],  and  #233–251
[DKQWHLEGSFPVLATEPPK]).
To determine whether the activity was associated with
βA3-crystallin  but  not  with  βB1-  or  βB2-crystallin,  the
recombinant βA3- and βB1-crystallins along with purified α-
crystallin proteinase were examined by HPLC using a size-
exclusion TSK G-3000 PWXL column. The recombinant βA3/
A1-crystallin was purified as previously described [31]. The
recombinant  protein  preparations  before  and  after
deoxycholate treatment were HPLC separated using a TSK
G-3000  PWXL-column,  and  the  column  fractions  were
examined  for  proteinase  activity.  The  recombinant  βA3-
crystallin exhibited proteinase activity, which co-eluted with
proteinase purified from the α-crystallin fraction (Figure 5).
No such activity was found with βB1- and βB2-crystallins (the
βB2-crystallin result is not shown).
Structural  changes  in  βA3-crystallin  following  proteinase
activation  upon  sodium  deoxycholate  treatment:  Upon
activation of the His-tagged WT βA3-crystallin (Mr ~32 kDa,
Figure  6,  lane  1,  NH2-terminal  sequence:  MRGSH  [the
sequence represented His-tag]) with deoxycholate and size-
exclusion HPLC, the proteinase activity-containing fraction
showed  an  NH2-terminally  cleaved  major,  25  kDa  βA3
species (Figure 6, lane 2; NH2-terminal sequence: MAQTN)
and  several  aggregated  species.  The  partial  NH2-terminal
sequencing showed that the 25 kDa species was generated
upon  cleavage  at  the  K17-M18  bond  in  the  NH2-terminal
extension arm of WT βA3-crystallin. This cleavage site was
different than the cleavage site (N22-P23) that we have reported
earlier [20] during the proteinase activation. This difference
could be due to the His-tag in the WT βA3-crystallin. The
truncated  25  kDa  species  predominantly  contained  an  α-
helical  structure  compared  to  the  β-sheet  structure  in  the
untruncated 32 kDa WT βA3-crystallin (Figure 7A; WT βA3:
β-sheet 51% and α-helix 34%; truncated 25 kDa βA3 with
Figure  4.  SDS–PAGE  analysis  of  five  proteinase  preparations
purified from five separate α-crystallin fractions. The purification
was performed by the three-step procedure described in Methods.
Lanes 1-5 show five different purified proteinase preparations from
five separate α-crystallin fractions. Note that all five preparations
reproducibly showed three bands that are identified as 1, 2, and 3.
TABLE 2. PURIFICATION OF α-CRYSTALLLIN-ASSOCIATED PROTEINASE FROM 60 TO 70-YEAR-OLD HUMAN LENSES.
Fractions Protein (mg/ml) Enzyme (e.u./ml)* Specific activity**
1. α-crystallin-sodium deoxycholate-treatment 3.5 1.6 0.457
2. Agarose A 1.5 m chromatography 0.44 14.8 33.6
3. Non-denaturing gel electrophoresis 0.08 2.4 30
4. Size-exclusion HPLC 0.004 2 500
Proteinase activity was determined following detergent treatment of the α-crystallin fraction and size-exclusion HPLC using a
TSK G-3000 PWXL column. An asterisk indicates that one enzyme unit (e.u.) is defined as the production of 0.1 nanomole of
7-amino 4-methyl coumarin per ml. The double asterisk denotes that specific activity is given in the measurement of e.u./mg of
the protein.
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1878proteinase activity: β-sheet 11% and α-helix 86%). Similarly,
compared to the 32 kDa WT βA3-crystallin, the truncated
25 kDa βA3-crystallin species exhibited a red shift in its
intrinsic Trp fluorescence spectrum (Figure 7B) and a blue
shift during binding to a hydrophobic probe ANS (8-anilino-1
naphthalene sulfate; Figure 7C).
A single Arg-bond hydrolyzing proteinase exists in different
fractions of human lenses: The four experiments as described
below  suggested  that  the  same  Arg-bond  hydrolyzing
proteinase exists in the WS protein, α-crystallin, βH-crystallin,
and membrane fractions of human lenses. Six pooled lenses
of 30 to 40-year-old donors were used in these experiments.
Following  size-exclusion  Agarose  A1.5  m
chromatograph of either the WS protein, α-crystallin, or βH-
crystallin  fractions,  very  little  proteinase  activity  was
observed in the column fractions with either the colorimetric
or  fluorometric  substrates.  However,  after  treatment  with
sodium deoxycholate and fractionation by a size-exclusion
Agarose  A1.5  m  column,  each  fraction  showed  enzyme
activity. The enzyme from each of the four fractions eluted in
fractions 35-50 (in the βH-crystallin region), suggesting their
identical molecular weights (Figure 8A-D).
Figure 5. Comparison of elution profiles at 280 nm during size-
exclusion HPLC of purified proteinase from the α-crystallin fraction,
recombinant  βA3/A1-crystallin,  and  recombinant  βB1-crystallin.
The  recombinant  proteins  were  treated  with  1%  sodium
deoxycholate  (w/v)  before  their  chromatography  (TSK  G3000
PWXL). The proteinase activity was determined by the incubation of
column fractions with BAPNA at 37 °C for 10 h.
To further determine whether the enzyme from the above
four fractions had an identical molecular weight, fractions
35-50  (Figure  8A-D),  recovered  after  Agarose
chromatography from each of the four fractions, were pooled
separately  and  analyzed  by  size-exclusion  HPLC  using  a
TSK-G-4000 PWXL column. Again, the proteinase activity
Figure 6. SDS–PAGE analysis of recombinant WT βA3-crystallin
and after its treatment with sodium deoxycholate and size-exclusion
HPLC. Lane 1 shows WT βA3-crystallin (untreated), and lane 2
shows  WT  βA3-crystallin  with  proteinase  activity  (after
deoxycholate treatment) and size-exclusion chromatography.
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1879from the four fractions co-eluted (Figure 9A), suggesting their
identical molecular weights.
It  was  determined  by  mixing  and  non-denaturing  gel
electrophoresis that the four proteinase preparations, which
were  isolated  from  the  above  four  fractions,  co-eluted.
Aliquots  from  proteinase  fractions  35-50  of  the  four  lens
fractions (Figure 8A-D) were combined. Upon analysis by a
preparative nondenaturing gel electrophoresis using a 10%
Figure 7. Structural changes in sodium deoxycholate-treated, 25 kDa
βA3-crystallin  species  with  proteinase  activity  compared  to
untreated, 32 kDa WT βA3-crystallin without enzyme activity. These
preparations were obtained as described in Figure 6. A: The far UV-
CD spectra show that the truncated 25 kDa βA3-species (red line)
contains a greater level of alpha helical content than the WT-βA3
(black line). B: The intrinsic Trp fluorescence spectra show a red
shift in the truncated 25 kDa βA3-species (red line) as compared to
the WT-βA3 (black line). C: The fluorescence spectra after ANS-
binding show a blue shift in the truncated 25 kDa βA3-species (red
line) as compared to the WT-βA3 (black line).
polyacrylamide  gel,  a  single  proteinase  activity  peak  was
observed (Figure 9B).
Figure  8.  Proteinase  activity  in  four  fractions  (WS  proteins,  α-
crystallin,  βH-crystallin,  and  membrane  fractions)  following
treatment with sodium deoxycholate and size-exclusion Agarose
A1.5 m chromatography. WS proteins (A), α-crystallin fraction (B),
βH-crystallin fraction (C), and membrane fraction (D). Each fraction
was first isolated from a homogenate of six pooled lenses of donors
30–40 years old by Agarose A1.5 m chromatography. Next, each
fraction was treated with the detergent and fractionated by the size-
exclusion chromatography, and the column fractions were examined
for their absorbance at 280 nm (red line) and proteinase activity
(green line) with BAPNA as a substrate. Note that the proteinase
activity eluted in the identical fractions during chromatography from
each of the four fractions.
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1880To  exclude  the  possibility  that  one  or  more  of  the
proteinase  may  have  degraded  during  the  above
nondenaturing gel electrophoresis, the caseinolytic activity of
individual  proteinase  from  the  four  fractions  following
nondenaturing gel electrophoresis was determined. As shown
in Figure 9C, the proteinase from all four fractions showed
co-migrating caseinolytic activity bands. Together, the above
data  suggest  that  the  same  proteinase  exists  in  all  four
fractions.
Characterization of properties of the α-crystallin-associated
proteinase:
Effect  of  proteinase  inhibitors  on  α-crystallin-
associated proteinase—The pI of the α-crystallin proteinase
was found to be between 4.5 and 5.0. When incubating the
Figure  9.  Comparison  of  properties  of  Arg-bond  hydrolyzing
proteinase isolated from the WS protein fraction, the α-crystallin
fraction, the βH-crystallin fraction, and the membrane fraction of
human lenses. A: Size-exclusion HPLC analysis is shown of the Arg-
bond hydrolyzing proteinase purified from the WS protein fraction
(red dotted line), the α-crystallin fraction (green dotted line), the βH-
crystallin fraction (blue dotted line), and the membrane fraction
(black dotted line). B: Nondenaturing gel electrophoresis is shown
of  the  combined  proteinase  preparations  from  the  WS  protein
fraction, α-crystallin fraction, βH-crystallin fraction, and membrane
fraction.  Note  that  a  single  proteinase  peak  was  observed  on
combining  proteinases  isolated  from  all  four  fractions.  C:
Caseinolytic  activity  of  the  four  proteinases  isolated  from  WS-
protein fraction (lane 1), α-crystallin fraction (lane 2), βH-crystallin
fraction (lane 3), and membrane fraction (lane 4). Note that a co-
migration caseinolytic activity of the four proteinases on a non-
denaturation gel was observed.
purified  proteinase  with  metalloproteinase,  cysteine
proteinase, and serine proteinase inhibitors, only the serine-
proteinase inhibitors exhibited an inhibition of the enzyme,
suggesting its serine-type nature.
Proteolysis  of  bovine  recombinant  γ-crystallins—
Proteolysis  of  the  bovine  recombinant  γB-,  γC-,  and  γD-
crystallins was examined by the proteinase (isolated from the
lens  membrane  fraction).  As  stated  above  in  Methods,
individual  crystallins  were  incubated  at  the  ratio  of  1:40
(proteinase:crystallin)  for  up  to  48  h  at  37  °C.  After
withdrawing  the  aliquots  at  0  h,  24  h,  and  48  h  during
proteolysis and analysis by SDS–PAGE, the γB-crystallin
exhibited resistance to proteolysis by the enzyme, but both
γC- and γD-crystallins were proteolyzed producing three and
six major fragments, respectively (Figure 10, lanes 7 and
10).The  partial  NH2-terminal  sequence  analysis  of  γD-
crystallin fragments showed that the following peptide bonds
were cleaved: M1-G2 in fragment #1 (~19-kDa), Q54-Y55 in
fragment #2 (~14-kDa), M70-G71 in fragment #3 (~12-kDa),
and Q103-M104 in fragment #4 (~10 kDa). The cleavage sites in
fragments #5 and #6 could not be determined because of the
presence of multiple polypeptides. In summary, the major
cleavage sites in γD-crystallin by the proteinase were at M1-
G2, Q54-Y55, M70-G71, and Q103-M104.
DISCUSSION
There were four important findings in this study: (1) The βA3-
crystallin  proteinase  existed  in  an  inactive  state  in  the α-
Figure 10. Time-dependent proteolysis of bovine recombinant γB-,
γC-, and γD-crystallins by the human lens membrane proteinase. The
incubation periods are shown at the bottom of the gel, and the reaction
constituents  are  shown  at  the  top  of  the  gel.  The  proteolyzed
fragments are identified with numbers, and only the fragments from
γD-crystallin were used for partial NH2-terminal sequence analysis.
Molecular Vision 2008; 14:1872-1885 <http://www.molvis.org/molvis/v14/a222> © 2008 Molecular Vision
1881crystallin fraction, and the enzyme was activated following
detergent  treatment.  (2)  The  recombinant  βA3-crystallin
when activated with sodium deoxycholate and size-exclusion
HPLC exhibited proteinase activity, which was accompanied
by cleavage at K17-M18 bond in the NH2-terminal extension
arm. The appearance of proteinase activity was accompanied
by secondary and tertiary structural changes. (3) The enzyme
was  present  in  three  separate  fractions  (α-crystallin,  βH-
crystallin, and membrane fractions) of human lenses. (4) The
proteinase exhibited in vitro proteolysis of human αA- and
αB-crystallins and bovine γC- and γD-crystallins. The first
finding  suggests  the  potential  role  of  α-crystallin  as  a
proteinase inhibitor as evident from previous studies [23,24,
26]. The second finding suggests that the activation of the
proteinase  activity  in  the  recombinant  βA3-crystallin  was
accompanied  by  cleavage  in  the  NH2-terminal  arm  and
secondary  structural  changes,  which  support  our  previous
finding that truncation in the NH2-terminal arm was needed
for the activation of proteinase activity in the human lens
βA3-crystallin [20]. The third finding of the presence of the
same enzyme in the α-crystallin and membrane fractions in
addition to the βH-crystallin fraction suggests an age-related
aggregation of βA3-crystallin with α-crystallin and later the
localization of the aggregate with the membrane. The fourth
finding suggests that the enzyme, although remaining in an
inactive  state  in  the  α-crystallin  fraction,  is  capable  of
proteolyzing αA-, αB-, and γ-crystallins. These findings are
significant in view of our present limited knowledge about in
vivo physiologic and biochemical relevance of βA3-crystallin
proteinase activity.
Our studies have shown that αA- and αB-crystallins form
aggregates  with  βA3-crystallin,  which  occurs  due  to
hydrophobic  interaction  (unpublished  results).  We
hypothesize that with deoxycholate treatment, the enzyme
dissociated from α-crystallin because of its greater solubility
in the detergent compared to α-crystallin. Once released from
the α-crystallin fraction upon detergent treatment, the enzyme
elutes as a lower molecular weight species (in the βH-crystallin
region) compared to the α-crystallin. A previous report has
shown  that  sodium  deoxycholate  treatment  disrupted  the
native oligomeric structures of both αA- and αB-crystallins
and  resulted  in  their  tetrameric  state  without  significant
changes in their secondary structures [37]. However, we did
not observe the tetrameric state of α-crystallin. Instead, the
crystallin eluted in the void volume during size-exclusion
Agarose A1.5 m chromatography. This could be due to the
removal  of  the  detergent  from  α-crystallin  following
chromatography that might have led to the reorganization of
the α-crystallin oligomer back to the original state. Indeed, the
excess of detergent was recovered as a separate peak after the
elution  of  the  proteinase  during  Agarose  A1.5  m
chromatography. Previous reports have suggested potential
binding  of  proteins  via  hydrophobic  interactions  with  α-
crystallin. The labeling of an intrinsic membrane protein with
the probe, trifluoromethyl-3-(~z-[' I] iodophenyl) diazirine,
showed that α-crystallin contains hydrophobic regions on its
surface, which might enable it to make contact with the lipid
bilayer [38]. The interactions between α-crystallin and the
membrane  is  not  membrane  lipid-specific  but  rather  α-
crystallin aggregate-specific [39], and the binding of αA- and
αB-crystallins  to  the  lens  membrane  is  via  hydrophobic
interactions [40]. Carver et al. [41] have suggested that α-
crystallin acts as an anionic surfactant during interaction with
proteins to prevent precipitation of the partially unfolded form
of proteins. Furthermore, the binding of α-crystallin to form
a complex with a proteolytic enzyme has also been shown,
i.e., a complex formation with prochymosin during refolding
but not with active chymosin [42]. Prochymosin is a zymogen
of  chymosin,  which  is  a  milk-clotting  enzyme  with  low
proteolytic  activity.  Previously,  our  results  showed  that
deoxycholate treatment leads to a redistribution of different
species of the human lens β-crystallin as represented by the
generation  of  new  aggregates,  and  these  species  were
originally  not  present  in  detergent-untreated  β-crystallins
[20]. Taken together, the association of proteinase with α-
crystallin  seems  to  be  through  hydrophobic  interactions,
which resulted in the release of the proteinase when disrupted
by a detergent. Although proteolysis of both αA- and αB-
crystallins was seen through in vitro incubation, whether the
enzyme activity was acquired before or after dissociation from
α-crystallin is presently unclear.
The proteinase was purified about 500 fold with a 1,094
fold  increase  in  specific  activity  following  the  three-step
purification  method.  SDS–PAGE  analysis  on  the  highly
purified proteinase preparation showed three protein bands,
which were identified as βB1-, βB2-, and βA3-crystallins by
the ES-MS/MS mass spectrometric method. Among these
crystallins,  only  recombinant  βA3-crystallin  showed
proteinase activity. The recombinant human βA3-crystallin
used in this study was purified to almost homogeneity by a
Ni2+-affinity column and showed only a single band of 32 kDa
during SDS–PAGE and a single spot on a two-dimensional
gel electrophoretic analysis (results not shown). Detergent
treatment and the activation of the enzyme activity in the
crystallin resulted not only in its degradation but also the
presence of several yet to be identified species. These species
could  be  degradation  products  of  the  crystallin  and  their
multimers.
It was surprising that the purified proteinase showed a
complex of βB1-, βB2-, and βA3-crystallins, and the complex
of the three crystallins remained together during the three
purification  steps.  Our  attempts  to  dissociate  the  three
crystallins  from  the  complex  by  an  ion-exchange  column
chromatographic method were unsuccessful. However, such
complexes with αA- and αB-crystallins in the HMW proteins
of both young and old human lenses were shown in our recent
study [43].
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1882As stated above, α-crystallin showed inhibition of both
trypsin and elastase during in vitro experiments [24,26]. Our
recent studies about the interaction of human αA- or αB-
crystallins with βA3-crystallin through the two-hybrid system
and in vivo FRET (fluorescence resonance energy transfer)
have  also  suggested  interactions  among  the  crystallins
(unpublished  results).  Therefore,  we  speculate  that  the
inhibition of the enzyme by α-crystallin might be an in vivo
mechanism to prevent unwanted proteolysis of αA- and αB-
crystallins  and  to  preserve  their  chaperone  activity.  Such
speculation is strengthened by the fact that the same proteinase
was present in an inactive state in α-crystallin, βH-crystallin,
and membrane fractions of human lenses. This could be due
to age-related distributional changes in a complex with α-
crystallin and βA3-crystallin. This is also consistent with our
results showing that βA3-crystallin exists in both urea soluble
and urea insoluble fractions of the WI protein fraction of
human lenses [17,18]. Although the membrane fraction was
prepared by the extensive urea washing method as described
in the literature [6], a need for activation of the proteinase by
a detergent from this fraction suggests the existence of an
inactive enzyme.
Human  βA3/A1-crystallin  undergoes  several
posttranslational  modifications  that  include  S-methylation,
glutathiolation, and truncation [44]. A loss 4 and 18 NH2-
terminal residues in βA3/A1-crystallin at an early stage of life
(i.e.,  three  years  of  age)  has  been  shown  [16,19].  This
truncation  of  the  NH2-terminal  extension  at  a  very  early
developmental stage does not significantly alter the structural
properties. Further, three of the five NH2-terminal truncations
in the crystallin were found to be adjacent to a proline residue
(i.e., N4-P5, P7-G8, and G10-P11) [45]. A comparison of nuclear
and  cortical  βA3/A1-crystallins  from  11-year-old  and  19-
year-old  human  lenses  showed  more  truncation  among
nuclear than cortical βA3/A1-crystallins in both ages [44].
Our  results  also  showed  that  the  majority  of  age-related
degradation  in  human  βA3/A1-crystallins  occurred  at  the
NH2-terminal region with a major cleavage site at the E39-
N40  bond  [15].  Recently,  we  identified  several  truncated
species of βA3/A1- and βB1-crystallins in human cataractous
lenses that were absent in normal lenses [17,18]. Because our
recent study [31] showed that the NH2-terminal domain is
relatively more stable than the COOH-terminal domain in
human  βA3-crystallin,  the  truncation  of  the  NH2-terminal
regions might impair its stability to form complexes with other
β-crystallins and might lead to aggregation with α-crystallin.
As  stated  above,  the  Arg-bond  hydrolyzing  activity  is
associated  with  a  truncated  βA3/A1-crystallin  [20],  and
therefore, the regulation of the enzyme activity in vivo might
involve the prevention of truncation of βA3/A1-crystallin and
the  inhibition  of  the  enzyme  activity  of  the  truncated
crystallin.
Several important questions emerge from this study. The
activation  mechanism  of  the  crystallin  proteinase  and  its
association  with  different  crystallins  including  the  lens
membrane remain to be studied. Further, an understanding of
the molecular mechanism of the proteinase inhibition by α-
crystallin in relation to the chaperone function of the latter is
needed.  In  future  studies,  we  will  utilize  α-crystallin-
associated proteinase as the model system to answer these
questions.
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